Filing
1st Quarter - Report
Lobbying activity
3
GFI signed onto an industry letter to U.S. Department of Health and Human Services, the Department of Agriculture, and the Environmental Protection Agency highlighting the importance of biotechnology to the Make America Healthy Again agenda.
Revisions to the Producing Real Opportunities for Technology and Entrepreneurs Investing in Nutrition Act, in its entirety; The Farm Bill, all provisions pertaining to alternative proteins and provisions pertaining to Centers of Excellence.
Discussions with congress about funding for alternative protein research from the National Defense Authorization Act (NDAA), from the Distributed Bioindustrial Manufacturing Program, and from the USDA Agriculture and Food Research Initiative.